Fig. 72From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseTop-ranked docking pose of compounds C8620 (a) and C8666 (b) [98]Back to article page